logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Pharmacological Reports cover

Pharmacological Reports

IF3.8
Papers3124
Citations6243
Journal Papers 4247
Publication Date
delete
Sex-dependent and long-term effects of cisplatin on bone mineral density in juvenile mice
deletePharmacological Reports
IF3.8
delete2026-10-08
delete0
PREAI
deleteHéctor Fabián Torres-Rodríguez; Santos Adrián Pérez-Reyes; Denisse Arlette Santiago-Méndez; Carla Gabriela Aguilar-Campos; Laura Yanneth Ramírez-Quintanilla; Arisai Martínez-Martínez; Enriqueta Muñoz-Islas; Juan Miguel Jiménez-Andrade
deleteShare
deleteSave
Lithium pretreatment does not affect pilocarpine-induced seizure-like activity in zebrafish larvae
deletePharmacological Reports
IF3.8
delete2026-09-29
delete0
deleteOAAI
deleteMarta Marszałek-Grabska; Monika Hułas-Stasiak; Saadat Bekenova; Anna Grenda; Michał Szulc; Camila V. Esguerra; Sohee Kim; Waldemar A. Turski; Kinga Gaweł
deleteShare
deleteSave
Tryptamide (nicotredole) revisited: re-examining a forgotten anti-inflammatory agent by large-scale target profiling and ADMET studies
deletePharmacological Reports
IF3.8
delete2026-09-29
delete0
deleteOAAI
deleteKatarzyna Szczepańska; Tadeusz Karcz; Ryszard Bugno; Katarzyna Kaczorowska; Beata Duszyńska; Andrzej J. Bojarski
deleteShare
deleteSave
Isoflavones as multi-target modulators in glioma and neuroblastoma: a mini-review
deletePharmacological Reports
IF3.8
delete2026-09-29
delete0
deleteOAAI
deleteWojciech Paździora; Agnieszka Galanty
deleteShare
deleteSave
Deciphering the allosteric landscape of 5-HT2 receptors: integrated molecular dynamics and fragment molecular orbital analyses of activation mechanisms
deletePharmacological Reports
IF3.8
delete2026-09-25
delete0
deleteOAAI
deletePaweł Śliwa; Karina Pakosz; Aleksandra Banach
deleteShare
deleteSave
Pharmacological targeting of ferroptosis in cancer: mechanisms, tumor immunity, and translational challenges
deletePharmacological Reports
IF3.8
delete2026-09-25
delete0
deleteOAAI
deleteAleksandra Zdanowicz; Bhaskar Pradhan; Beata Pyrzyńska; Dagmara Otto-Ślusarczyk; Marta Struga
deleteShare
deleteSave
Gastrointestinal adverse events associated with axitinib: pharmacovigilance analysis of the Japanese adverse drug event report database
deletePharmacological Reports
IF3.8
delete2026-09-24
delete0
PREAI
deleteKeiko Hosohata; Riku Nakamoto; Yuko Kanbayashi
deleteShare
deleteSave
Transcriptional and epigenetic regulation of the cannabinoid receptor type-1 (CB1R) in health and disease: an overview
deletePharmacological Reports
IF3.8
delete2026-09-22
delete0
deleteOAAI
deleteKeyla Tamara Cerdán-Centeno; Julio Morán; Abel Santamaría
deleteShare
deleteSave
Is teriparatide linked to osteosarcoma? A disproportionality analysis of the FAERS database
deletePharmacological Reports
IF3.8
delete2026-09-17
delete0
deleteOAAI
deleteNunzia Balzano; Raffaella Di Napoli; Ludovica Vittoria Laino; Rosanna Ruggiero; Concetta Rafaniello; Liberata Sportiello; Francesco Rossi; Annamaria Mascolo; Annalisa Capuano
deleteShare
deleteSave
Cancer therapy-related cognitive impairment, part 1: an integrative clinical–mechanistic framework from phenotypes to convergent neurobiological pathways
deletePharmacological Reports
IF3.8
delete2026-09-17
delete0
deleteOAAI
deleteSelene Tertemiz; Jan Detka; Kinga Sałat
deleteShare
deleteSave
Tetrahydrocurcumin suppresses FcεRI- and MRGPRX2-mediated mast cell activation and attenuates peanut-induced anaphylaxis in an in vitro and in vivo study
deletePharmacological Reports
IF3.8
delete2026-09-14
delete0
PREAI
deleteGyeongseo Suk; Jiyoon Mun; Ji Yeon Park; Minae Park; Ee Taek Hwang; Hae Woong Choi
deleteShare
deleteSave
Drugs associated with retroperitoneal fibrosis: assessment of the 1969–2025 Food and Drug Administration (FDA) pharmacovigilance database
deletePharmacological Reports
IF3.8
delete2026-09-11
delete0
deleteOAAI
deleteSara Baldini; Nicolo’ Schifano; Kiyara Fernando; Matteo Coschignano; Alessio Villano; Ilaria Elena Zais; Gabriele Antonini; Paolo Capogrosso; Federico Deho’
deleteShare
deleteSave
Cancer therapy-related cognitive impairment, part 2: from bench to bedside—and back: why candidate therapies for cancer therapy-related cognitive impairment fail to translate
deletePharmacological Reports
IF3.8
delete2026-09-11
delete0
deleteOAAI
deleteSelene Tertemiz; Jan Detka; Kinga Sałat
deleteShare
deleteSave
Unveiling novel transcriptomic prognostic biomarkers for specific breast cancer subtypes and treatment regimens
deletePharmacological Reports
IF3.8
delete2026-09-09
delete0
PREAI
deleteKrittin Pitinanon; Chotiphuk Kusalasaiyanon; Wathunya Hawhan; Yu-Yu Liu; Pasrawin Taechawattananant; Varalee Yodsurang
deleteShare
deleteSave
Gut microbiota as a modulator of HDAC: insights into Alzheimer’s disease treatment
deletePharmacological Reports
IF3.8
delete2026-09-09
delete0
PREAI
deleteEkta Verma; Shweta Mishra; Hanish Singh Jayasingh Chellammal; Prasanna Shama Khandige; Amin Gasmi
deleteShare
deleteSave
Interactions of ACEA and WIN 55,212-2 mesylate with temozolomide and cisplatin in neuroblastoma and glioblastoma cell lines: an isobolographic analysis
deletePharmacological Reports
IF3.8
delete2026-09-09
delete0
deleteOAAI
deleteKatarzyna Załuska-Ogryzek; Paula Wróblewska-Łuczka; Agnieszka Góralczyk; Michał Chojnacki; Jarogniew J. Łuszczki
deleteShare
deleteSave
Signs of antidepressant-like effects of temozolomide as measured in the forced-swim test in adult rats
deletePharmacological Reports
IF3.8
delete2026-09-01
delete0
PREAI
deleteLaura Gálvez-Melero; M. Julia García-Fuster
deleteShare
deleteSave
The anti-CEACAM1 agonistic antibody CCM5.01 inhibits the growth of colon cancer cell lines in 2D and 3D models
deletePharmacological Reports
IF3.8
delete2026-08-31
delete0
deleteOAAI
deleteShiran Niazov; Ilan Zaffran; Ofra Benny; Micha Ben-Zimra; Francesca Levi-Schaffer
deleteShare
deleteSave
Effects of lovastatin on cortical excitability, E/I balance, and antioxidant markers in a case series of patients with drug-resistant epilepsy: a proof-of-concept study
deletePharmacological Reports
IF3.8
delete2026-08-26
delete0
deleteOAAI
deleteSulaiman I. Abuhaiba; Isabel Catarina Duarte; Francisco Sales; Miguel Castelo-Branco
deleteShare
deleteSave
preSCRIPT: Large-scale prescription search and annotation engine for pharmacogenomic studies
deletePharmacological Reports
IF3.8
delete2026-08-24
delete0
deleteOAAI
deleteMaria Pieczarka; Paweł Pieńkowski; Paula Konowalska; Sylwia Grubarek; Jacek Hajto; Dżesika Hoinkis; Marcin Piechota; Małgorzata Borczyk; Michał Korostyński
deleteShare
deleteSave